Work

Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial

Year: 2012

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Bone Marrow Transplantation

DOI: 10.1038/bmt.2011.261

Authors: M H Jagasia, R Abonour, G D Long, B J Bolwell, G G Laport, T B Shore, S Durrant, J Szer, M-G Chen, R Lizambri, E K Waller

Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center, Indiana University Indianapolis, Duke University, Duke Medical Center, Cleveland Clinic, Stanford Medicine, Stanford University, NewYork–Presbyterian Hospital, Weill Cornell Medicine, Royal Brisbane and Women's Hospital, The Royal Melbourne Hospital, Amgen (United States), Emory University, Winship Cancer Institute

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Amgen

OpenAlex ID: W2092696529

FWCI: 1.343

Cites: 17

Cited by: 24

Related to: 10